Omid Veiseh, Ph.D. Class of 2009

Dr. Omid Veiseh is currently a postdoctoral fellow at the David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT). Working in the laboratory of Institute Professor Robert S. Langer and under the co-mentorship of Professor Daniel G. Anderson, his research is focused on the development of smart bioresponsive polymeric nanoparticles for drug delivery and tissue-engineering applications aimed towards the treatment of diabetes and cancer.

Dr. Veiseh obtained his Bachelors of Science degree in Cell Biology from Western Washington University in 2002 and his Dual Ph.D. in Materials Science & Engineering and Nanotechnology from the University of Washington (UW) in 2009. His doctoral dissertation work in the laboratory of Professor Miqin Zhang was aimed at the development of multifunctional nanoparticles for diagnosis and treatment of brain tumors. At UW, Dr. Veiseh received two years of funding through the Center for Nanotechnology (CNT) NSF/NIH IGERT fellowship program.

Moving forward, Dr. Veiseh is eager to pursue a tenure-track facility position establishing an independent, interdisciplinary nanomedicine research program aimed towards the development and commercialization of the next generation of nanoparticle based diagnostics and therapeutics for debilitating human diseases.

Michael Nash, Ph.D. Class of 2010

Michael Nash received a dual PhD degree in Bioengineering and Nanotechnology from the University of Washington in December of 2010. In March of 2011, Michael crossed the Atlantic and began a postdoctoral position at the Center for Nanotechnology, Ludwig-Maximilians University of Munich, Germany, working in the applied biophysics group of Prof. Hermann Gaub. Supported by an Alexander von Humboldt Foundation postdoctoral fellowship, Michael’s research is focused on investigating protein-protein interactions, and structure-function relationships at the single-molecule level, as well as developing single-molecule surface assembly methods using the atomic force microscope. In the future, Michael sees his research focusing on the design of new bioconjugate nanoscale materials for applications in the biodiagnostic, therapeutic, and renewable energy sectors.

Michael graduated from the University of California Los Angeles in 2006 with a B.S. in cybernetics before coming to U.W. to work under Professors Patrick Stayton, Paul Yager, and Allan Hoffman. His PhD dissertation dealt with development of new formulations of magnetic and gold nanoparticles for disease diagnosis in low-resource settings.